TMH Spotlight: Former Woodside (ASX:WDS) boss to head NewCo, Siren Gold (ASX:SNG) increases global resource at Supreme, NZ

Trading platform City Index has released its list of the most-traded stocks worldwide.

Taking out the top spot was Tesla, which averaged 3.5 million monthly searches globally – that’s over 1.5 million more than the runner-up, BP.

When looking at the top 20 shares by volume in Australia, Magnum Mining and Exploration (MGU) took out the gold medal, closely followed by Creso Pharma (CPH) and Mount Ridley Mines (MRD).

Meanwhile, Woodside (WDS) – or the number nine company in terms of value in Australia – has seen its former chief Peter Coleman announced as head of NewCo.

The new company will be formed through the merger of Allkem (AKE) and US company Livent.

Mr Coleman will chair the company, which is on its way to becoming a top three lithium producer by 2027. Allkem soared 15 and a half per cent, to $14.90.

Also in the materials sector, Siren Gold (SNG) has increased its global resource to 1.2 million ounces following the release of a resource estimate at its Supreme gold project in Reefton, New Zealand.

The company reported an MRE at its Supreme prospect of 103 thousand ounces at 2.7 grams per tonne gold at a 1.5 grams per tonne of gold cut-off.

The company’s next steps will focus on refining and identifying further drill targets in the area.  Siren Gold was trading at 11 cents.

GrainCorp (GNC) shares are on the rise after posting its first half financial results for 2023.

The company reported EBITDA of $383 million and a net profit after tax of $200 million.

GrainCorp cited its agribusiness and processing segments as the major contributors to its strong performance. Shares in GrainCorp last traded at $7.10.

To healthcare, and HeraMED (HMD) has climbed seven and a half per cent after securing a new contract.

The medical and tech company penned a deal with WA’s Joondalup Obstetrics and Gynaecology Group – or JOGG – to deploy its HeraCARE data-sharing platform for monitoring pregnancies.    

The new contract includes an initial purchase of 120 HeraCARE licences and HeraBEAT devices for a 12-month period, with JOGG to hand over a licensing fee of $690 per pregnancy. HeraMED was trading at 8.5 cents.